Home >> Top News >> FDA clears Panther Fusion Flu A/B/RSV assay

FDA clears Panther Fusion Flu A/B/RSV assay

Print Friendly, PDF & Email

Oct. 12, 2017Hologic has received 510(k) clearance from the FDA for its Panther Fusion Flu A/B/RSV assay for use on its Panther Fusion system.

The Panther Fusion is available as a full system or as a module that can be attached to existing Panther systems. The Panther Fusion is capable of running polymerase chain reaction assays in addition to tests based on transcription-mediated amplification.

“Hologic has long-standing expertise in flu extending back to the introduction of ProFlu+, the first FDA-cleared Flu A/B/RSV assay on the market in 2008,” Tom West, president of the Diagnostic Solutions Division, Hologic, said in a statement. “This expertise has translated to the development of a test with excellent performance, and that test is now available on our integrated platform, which fully automates all aspects of testing, from sample to result.”

More top news

x

Check Also

Aptima HBV Quant Assay gets PMA approval

Jan. 30, 2018—Hologic announced the FDA has granted PMA approval for the Aptima HBV Quant...

X